The Origin and Role of Thromboembolism in the Pathogenesis of Ischaemic Stroke

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Edinburgh

About this trial

Ischaemic stroke is usually due to occlusion of a cerebral artery by thrombus. However, it is often difficult to identify the source of thrombus, or to confirm thrombus as a cause of ischaemic stroke. Moreover, it is debated whether thrombosis plays any role in certain types of stroke such as lacunar stroke. In preliminary studies, the investigators have evaluated a novel clinical grade thrombus-specific radiotracer, 18F-GP1, which has a high specificity for the glycoprotein IIb/IIIa receptor on activated platelets. The investigations have demonstrated that 18F-GP1 is highly sensitive to in vivo thrombus formation and demonstrates avid binding to thrombus associated with myocardial infarction, pulmonary embolism and aortic bioprosthesis. This study will use this imaging approach to define the role and origin of thrombus in patients with ischaemic stroke, cryptogenic stroke and lacunar stroke.The investigators will also assess its added clinical value in assessing patients with ischaemic stroke.

Eligibility criteria

Qualifiers

Males and females ≥18 years old

Diagnoses of acute ischaemic stroke (within 21 days of symptom onset) as per American Heart and Stroke Association guidelines

Disqualifiers

Inability or unwillingness to provide informed written consent (ie lack capacity)

Inability to undergo the scanning protocol including ability to transfer onto the scanner

Women of child- bearing potential in whom pregnancy cannot be excluded

Contraindication to PET-CT scanning including estimated glomerular filtration rate <30 mL/min/1.73 m2

Trial design

Treatments tested in this trial

  • 18F-GP1 PET/CT
  • Agitated Contrast Echocardiogram
  • MRI Head
  • ECG Monitoring

Treatment groups

120 Participants
are divided into 1 treatment group

Sponsors and collaborators

University of Edinburgh

Lead sponsor

British Heart Foundation

Collaborator